Magnification-corrected photodynamic therapy

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 245, Issue 3, 2007, Pages 333-337

  Ansari Shahrezaei, Siamak ^a,b   Ergun, Erdem ^c   Chong, Robert ^b   Tufail, Adnan ^b   Wedrich, Andreas ^a   Stur, Michael ^d  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b MOORFIELDS EYE HOSPITAL   (United Kingdom)

^c Sanatorium Hera ^*  (Austria)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Choroidal neovascularization; Light fluence; Photodynamic therapy

Indexed keywords

BENZOPORPHYRIN DERIVATIVE;

ARTICLE; CALCULATION; EYE FUNDUS; HYPERMETROPIA; LENS; MYOPIA; PHOTODYNAMIC THERAPY; PREDICTION; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL NEOVASCULARIZATION;

CHOROIDAL NEOVASCULARIZATION; HUMANS; HYPEROPIA; LASERS; MODELS, BIOLOGICAL; MYOPIA; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS;

EID: 33947119776     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-006-0419-y     Document Type: Article

References (25)

1. Age-Related Eye Disease Study Research Group (2000) Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3. Ophthalmology 107:2224-2232
2. Altman DG, Bland JM (1983) Measurement in medicine: The analysis of method comparison studies. Statistician 32:307-317
3. Ansari-Shahrezaei S, Stur M (2005) Magnification-corrected indirect biomicroscopy of the optic nerve head. Graefes Arch Clin Exp Ophthalmol 243:257-262
4. Ansari-Shahrezaei S, Ergun E, Stur M (2006) The effect of digital measurement software on photodynamic therapy. Graefes Arch Clin Exp Ophthalmol 244:137-142
5. Ansari-Shahrezaei S, Ergun E, Stur M (2006) The effect of axial length on photodynamic therapy. Am J Ophthalmol 141:699-702
6. Ansari-Shahrezaei S, Ergun E, Stur M (2006) Digital area measurement of fundus landmarks. Graefes Arch Clin Exp Ophthalmol 244:649-653
7. Bennett AG, Rudnicka AR, Edgar DF (1994) Improvements on Littmann's method of determining the size of retinal features by fundus photography. Graefes Arch Clin Exp Ophthalmol 232:361-367
8. Fankhauser F, Durr U, Giger H, Rol P, Kwasniewska S (1996) Lasers, optical systems and safety in ophthalmology: A review. Graefes Arch Clin Exp Ophthalmol 234:473-487
9. Husain D, Gragoudas ES, Miller JW (1998) Photodynamic therapy. In: Berger JW, Fine SL, Maguire MG (eds) Age-Related Macular Degeneration. Mosby, St. Louis, pp 297-307
10. Husain D, Kramer M, Kenny AG, Michaud N, Flotte TJ, Gragoudas ES, Miller JW (1999) Effects of photodynamic therapy using verteporfin on experimental choroidal neovascularization and normal retina and choroid up to 7 weeks after treatment. Invest Ophthalmol Vis Sci 40:2322-2331
11. Kondo M, Ito Y, Miyata K, Kondo N, Ishikawa K, Terasaki H (2006) Effect of axial length on laser spot size during photodynamic therapy: An experimental study in monkeys. Am J Ophthalmol 141:214-215
12. Kramer M, Miller JW, Michaud N, Moulton RS, Hasan T, Flotte TJ, Gragoudas ES (1996) Liposomal benzoporphyrin derivative verteporfin photodynamic therapy: Selective treatment of choroidal neovascularization in monkeys. Ophthalmology 103:427-438
13. Littmann H (1982) Determination of the real size of an object on the fundus of the living eye [in German]. Klin Mbl Augenheilk 180:286-289
14. Littmann H (1988) Determining the true size of an object on the fundus of the living eye [in German]. Klin Mbl Augenheilk 192:66-67
15. Michels S, Hansmann F, Geitzenauer W, Schmidt-Erfurth U (2006) Influence of treatment parameters on selectivity of verteporfin therapy. Invest Ophthalmol Vis Sci 47:371-376
16. Miller JW, Schmidt-Erfurth U, Sickenberg M, Pournaras CJ, Laqua H, Barbazetto I, Zografos L, Piguet B, Donati G, Lane AM, Birngruber R, van den Berg H, Strong A, Manjuris U, Gray T, Fsadni M, Bressler NM, Gragoudas ES (1999) Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: Results of a single treatment in a phase 1 and 2 study. Arch Ophthalmol 117:1161-1173
17. Rassow B (1972) A model of Gullstrand's normal eye [in German]. Ophthalmologica 164:143-148
18. Reinke MH, Canakis C, Husain D, Michaud N, Flotte TJ, Gragoudas ES, Miller JW (1999) Verteporfin photodynamic therapy retreatment of normal retina and choroid in the cynomolgus monkey. Ophthalmology 106:1915-1923
19. Rudnicka AR, Burk RO, Edgar DF, Fitzke FW (1998) Magnification characteristics of fundus imaging systems. Ophthalmology 105:2186-2192
20. Sandberg MA, Tolentino MJ, Miller S, Berson EL, Gaudio AR (1993) Hyperopia and neovascularization in age-related macular degeneration. Ophthalmology 100:1009-1013
21. Schmidt-Erfurth U, Miller JW, Sickenberg M, Laqua H, Barbazetto I, Gragoudas ES, Zografos L, Piguet B, Pournaras CJ, Donati G, Lane AM, Birngruber R, van den Berg H, Strong HA, Manjuris U, Gray T, Fsadni M, Bressler NM (1999) Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: Results of retreatments in a phase 1 and 2 study. Arch Ophthalmol 117:1177-1187
22. Stur M, Ansari-Shahrezaei S (2001) The effect of axial length on laser spot size and laser irradiance. Arch Ophthalmol 119:1323-1328
23. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group (1999) Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: One-year results of 2 randomized clinical trials TAP Report 1. Arch Ophthalmol 117:1329-1345
24. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group (2001) Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: Two-year results of 2 randomized clinical trials - TAP Report 2. Arch Ophthalmol 119:198-207
25. Visudyne in Minimally Classic Choroidal Neovascularization (VIM) Study Group (2005) Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial. Arch Ophthalmol 123:448-457